- £374.86m
- £329.06m
- £1.95bn
- 53
- 58
- 89
- 78
Annual income statement for Impellam, fiscal year end - December 30th, GBP millions except per share, conversion factor applied.
R2019 January 4th | 2020 January 3rd | R2021 December 31st | 2021 January 1st | 2022 December 30th | |
|---|---|---|---|---|---|
| Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,267 | 2,255 | 1,580 | 2,001 | 1,947 |
| Cost of Revenue | |||||
| Gross Profit | 278 | 274 | 161 | 228 | 205 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,245 | 2,242 | 1,567 | 2,016 | 1,926 |
| Operating Profit | 22.5 | 13 | 13.7 | -15 | 21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 15.7 | 5.7 | 9.8 | -20.4 | 16.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12.9 | 4.8 | 3.3 | -21.4 | 14.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 13.2 | 5.8 | 8.2 | -21.4 | 25 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 13.2 | 5.8 | 8.2 | -21.4 | 25 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.489 | 0.327 | 0.073 | 0.05 | 0.356 |
| Dividends per Share | |||||
| Special Dividends per Share |